Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NewHaptics is a private assistive technology company developing tactile display systems that enable blind and visually impaired users to access digital information through refreshable braille and tactile graphics. The company emerged from University of Michigan research and uses a patented microfluidic, air-driven braille actuation approach designed to reduce cost while supporting multiline and full-page tactile displays. Its core commercial product effort is Codex, a multiline braille display intended to expand access to digital text, math, graphs, maps, and other spatial content. NewHaptics has been supported by NSF and NIH SBIR funding and has also raised venture financing to support commercialization. The company sits at the intersection of medtech, accessibility, and digital health rather than traditional therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NewHaptics.